Biotechnology · Paris, France · Founded 2014 · Privately Held (backing)
Developer of DNA printer technology designed to print synthetic nucleic acids for genomics and molecular biology applications. DNA Script is based in Paris, France and was founded in 2014. It was valued at $660 million at its later-stage round in Jan 2022, the last priced event on record. It has raised $299 million across 1 recorded round; the latest was a $192 million Series C in Jan 2022.
PMV mark · valuation
$659.7M
Oct 2026
Priced at
its later-stage round
Jan 2022
Total raised
$298.7M
Last round
Later Stage VC (Series C)
Jan 2022
Team — not yet on record
No current team members for DNA Script are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of DNA Script with a free account
·The complete investor list: 34 names
·Watch DNA Script: the Monday email on marks, rounds and moves
